Author:Shanghai Global South Academy Release date:2026-11-17 17:12:28Source:Shanghai Global South Academy
On the morning of September 24, 2026, the 13th lecture of the Rethinking the Global South series, co-organized by the Shanghai Institute for Global South Studies, Fudan Development Institute (FDDI), and the Global South Field Research Laboratory, Fudan University, was held in Room 210 of the Think Tank Building. Themed Moving Towards Innovative Health Interventions and Health Service System Development for Malaria Control: Opportunities for China-Africa Cooperation, the lecture featured Professor Salim Abdulla, Former Director and Chief Scientist of the Ifakara Health Institute (IHI) in Tanzania. Professor Duoquan WANG, Deputy Director of the Global Health Center at the National Institute of Parasitic Diseases (NIPD) of the Chinese Center for Disease Control and Prevention (China CDC), and Professor Jiayan HUANG, Director of the Department of Hospital Management at the School of Public Health, Fudan University, served as discussants. The event was hosted by Researcher Liangmin GAO from the Global South Field Research Laboratory, Fudan University and FDDI. Co-sponsored by the Shanghai Institute for Global South Studies, FDDI, and the Global South Field Research Laboratory, Fudan University, the lecture attracted more than 20 faculty members and students from inside and outside the university, as well as scholars from the biomedical industry and related fields, participating both online and offline.
Professor Salim Abdulla introduced the construction of the Ifakara Health Institute, an important research base for tropical diseases in Africa. The institute carries out full-chain research around malaria, including vector surveillance, new drug and vaccine evaluation, and human challenge trials for malaria, while also exploring innovative prevention and control technologies like drone-based mosquito eradication. He pointed out that although the burden of malaria in Africa has declined, cases are shifting to fragmented clustered epidemic sites, facing the reality of overlapping new and old diseases such as malaria, non-communicable diseases, and HIV/AIDS. The existing prevention and control tools are relatively outdated, and there is an urgent need to develop a new generation of intervention technologies for high-risk populations. At the same time, the lack of individual electronic health records at the grassroots level is a shortcoming in upgrading the health system. Drawing on China's malaria surveillance and response strategies, the institute has formed intervention schemes suitable for the African environment. He believes there is tremendous potential for China-Africa public health cooperation. Chinese antimalarial drugs and diagnostic reagents have largely entered the African market. In the future, both sides can advance joint R&D and local technology transfer for new drugs, vaccines, and vector control products, explore the scientific evaluation and registration of traditional medicine, jointly build related laboratories, and explore multilateral South-South cooperation fund mechanisms to simplify cross-border capital flows. Participating experts held discussions on topics such as laboratory construction, talent cultivation, localization of traditional Chinese medicine, and artemisinin resistance monitoring, reaching a consensus: China-Africa health cooperation cannot simply copy external models; it must adapt technologies locally to fit local realities, and coordinate full-chain construction including intellectual property, regulatory registration, supply chains, and talent reserves. This lecture established a platform for China-Africa public health dialogue, laying a foundation for future research synergy and joint talent cultivation.
Translated by FDDI
Full text in Chinese available at:
https://fddi.fudan.edu.cn/1e/69/c18985a794217/page.htm